For a preterm infant born at 33 weeks gestation, now 5 weeks corrected age, weighing 2.5 kg with anemia (hemoglobin 9 g/dL), should ferrous sulfate (FeSO4) and folic acid be administered, and what are the appropriate doses?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Iron and Folic Acid Supplementation for Preterm Infant with Anemia

Yes, oral ferrous sulfate supplementation is correct and should be initiated at 2–3 mg/kg/day of elemental iron (approximately 5–7.5 mg/day for this 2.5 kg infant), while folic acid supplementation at 56 mcg/kg/day (approximately 140 mcg/day) is also appropriate for this preterm infant with anemia.

Iron Supplementation

Indication and Timing

  • Preterm infants born at 33 weeks are at high risk for iron deficiency anemia due to limited iron stores, rapid growth, and phlebotomy losses during hospitalization 1.
  • Iron supplementation should be started by 2 weeks of age in low-birth-weight infants to prevent iron deficiency before neonatal stores are exhausted 1.
  • At 5 weeks corrected age with hemoglobin of 9 g/dL, this infant has developed anemia and requires therapeutic iron supplementation 2.

Dosing Recommendations

  • The standard dose is 2–3 mg/kg/day of elemental iron 2.
  • For a 2.5 kg infant, this translates to 5–7.5 mg/day of elemental iron 2.
  • To prescribe this using ferrous sulfate (which contains approximately 20% elemental iron), you would need 25–37.5 mg of ferrous sulfate daily 2.
  • Standard liquid ferrous sulfate preparations contain 15 mg elemental iron per mL (75 mg ferrous sulfate per mL), so the dose would be approximately 0.3–0.5 mL daily 2.

Formulation and Administration

  • Ferrous sulfate is the preferred formulation because it is the most cost-effective and has demonstrated efficacy in pediatric iron deficiency anemia 2.
  • Iron should be administered once daily or every other day to optimize absorption while minimizing side effects 2.
  • Co-administration with vitamin C (such as a small amount of orange juice if age-appropriate) enhances absorption 2.
  • Iron is best absorbed on an empty stomach when possible 2.

Treatment Duration

  • Continue iron supplementation for approximately 3 months after hemoglobin normalizes to fully replenish iron stores 2.
  • Monitor hemoglobin levels; expect an increase of at least 1 g/dL within 2 weeks of starting therapy 2.
  • Ferritin levels should increase within one month of treatment 2.

Important Caveat

  • While guidelines for parenteral nutrition recommend 200–250 mcg/kg/day of iron for preterm infants on PN 3, enteral iron supplementation is preferred over parenteral when tolerated 3.
  • Parenteral iron should only be considered if oral iron fails or is not tolerated 3, 2.

Folic Acid Supplementation

Indication and Dosing

  • Preterm infants up to 12 months of age should receive 56 mcg/kg/day of folic acid 4.
  • For a 2.5 kg infant, this equals approximately 140 mcg/day 4.
  • Folic acid requirements are increased in preterm infants due to rapid growth and cell division 4.

Evidence for Supplementation

  • Preterm infants fed human breast milk without fortification or formula with low folic acid content are at risk for folate deficiency, particularly if maternal supplementation was inadequate 5.
  • However, infants receiving fortified breast milk or preterm formula typically have adequate folate intake and may not develop deficiency 5.
  • Since this infant is 5 weeks corrected age and has anemia, supplementation is prudent to support erythropoiesis 4.

Safety Considerations

  • Folic acid doses should not exceed 0.4 mg (400 mcg) daily in therapeutic settings unless pernicious anemia (vitamin B12 deficiency) has been ruled out 6.
  • High-dose folic acid can mask vitamin B12 deficiency by correcting anemia while allowing neurologic damage to progress 6.
  • At the recommended dose of 140 mcg/day for this infant, this risk is minimal 4.

Clinical Monitoring

Follow-up Parameters

  • Check hemoglobin in 2 weeks to confirm response (expect ≥1 g/dL increase) 2.
  • Monitor ferritin at 1 month to assess iron store repletion 2.
  • Continue monitoring hemoglobin monthly until normalized, then every 2–3 months during continued supplementation 2.

When to Consider Alternative Therapy

  • If hemoglobin fails to rise by 1 g/dL within 2 weeks, consider 2:
    • Non-compliance or inadequate dosing
    • Ongoing blood loss
    • Malabsorption
    • Other causes of anemia (infection, hemolysis, vitamin B12 deficiency)
  • Intravenous iron is reserved for cases where oral iron is ineffective, not tolerated, or contraindicated 3, 2.

Common Pitfalls to Avoid

  • Do not delay iron supplementation in preterm infants; prophylaxis should ideally begin by 2 weeks of age 1.
  • Do not use iron polysaccharide complexes as they are more expensive and not superior to ferrous sulfate 2.
  • Avoid giving iron with tea, coffee, or calcium-rich foods as these inhibit absorption 2.
  • Do not give excessive folic acid (>400 mcg/day) without ruling out B12 deficiency 6.
  • Do not use parenteral iron as first-line therapy in this clinical scenario 3, 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.